No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
BAX Baxter International Inc
- 34.350
- -0.100-0.29%
Close May 22 16:00 ET
- 34.250
- -0.100-0.29%
Pre 05:35 ET
17.50BMarket Cap6.57P/E (TTM)
34.700High34.345Low2.78MVolume34.380Open34.450Pre Close95.88MTurnover0.55%Turnover Ratio6.54P/E (Static)509.58MShares49.12052wk High2.14P/B17.43BFloat Cap30.54852wk Low1.16Dividend TTM507.32MShs Float88.196Historical High3.38%Div YieldTTM1.03%Amplitude12.165Historical Low34.472Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Citi Maintains Baxter International Inc(BAX.US) With Hold Rating, Cuts Target Price to $38
Citi analyst Joanne Wuensch maintains $Baxter International Inc(BAX.US)$ with a hold rating, and adjusts the target price from $44 to $38.According to TipRanks data, the analyst has a success rate of
Express News | NYSE Order Imbalance 164538.0 Shares on Sell Side
Baxter International Is Maintained at Neutral by Citigroup
Baxter International Is Maintained at Neutral by Citigroup
Citigroup Maintains Neutral on Baxter Intl, Lowers Price Target to $38
Citigroup analyst Joanne Wuensch maintains Baxter Intl with a Neutral and lowers the price target from $44 to $38.
Baxter Intl Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/22/2024 9.73% Citigroup $44 → $38 Maintains Neutral 05/10/2024 15.51% TD Cowen → $40 Downgrades Buy → H
Express News | Baxter International Inc : Citigroup Cuts Target Price to $38 From $44
Comments
$Direxion Daily S&P Biotech Bear 3x Shares ETF (LABD.US)$ Baxter expands portfolio with new injectable products in U.S.![]()
1
Given Baxter International's low P/S ratio and inferior revenue outlook, investors expect limited growth for the future, posing a potential limit to the stock's rise.
Baxter's unappealing 2.9% ROE performance with significant debt use indicates increased business risk. High ROE, low debt companies are typically more qualitative.
News Highlights
$Tesla(TSLA.US$ shares fell by 1.57%, closing at $258.87. Its options trading volume is 1.91 million. Call contracts account for 59.1% of the whole trading volume. The most traded calls are contracts of $270 strike price that expire on October 13th. The total volume reaches 122,071 with an open interest of 32,331. The most traded puts are contracts of a $260 strike price that expires on October 13t...
$Tesla(TSLA.US$ shares fell by 1.57%, closing at $258.87. Its options trading volume is 1.91 million. Call contracts account for 59.1% of the whole trading volume. The most traded calls are contracts of $270 strike price that expire on October 13th. The total volume reaches 122,071 with an open interest of 32,331. The most traded puts are contracts of a $260 strike price that expires on October 13t...
20
Drugs used for weight loss like Ozempic pose a real risk to companies ranging from fast food restaurants to cigarette makers. Expect management teams of public companies to talk about them in their earnings calls.
Ozempic and Wegovy, two weight-loss medications, function by simulating the hormone that signals to people's brains when they are not hungry. Recent anecdotal data indicates that the medicine might reduce users' craving...
Ozempic and Wegovy, two weight-loss medications, function by simulating the hormone that signals to people's brains when they are not hungry. Recent anecdotal data indicates that the medicine might reduce users' craving...
11
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg